You are here:
SELENIUM COMPOUNDS MODULATE THE ACTIVITY OF RECOMBINANT RAT ASIII-METHYLTRANSFERASE AND THE METHYLATION OF ARSENITE BY RAT AND HUMAN HEPATOCYTES
Citation:
Walton, Felecia S, S. B. Waters, S. L. Jolley, E. L. LeCluyse, D J. Thomas, AND M. Styblo. SELENIUM COMPOUNDS MODULATE THE ACTIVITY OF RECOMBINANT RAT ASIII-METHYLTRANSFERASE AND THE METHYLATION OF ARSENITE BY RAT AND HUMAN HEPATOCYTES. CHEMICAL RESEARCH IN TOXICOLOGY 16:261-265, (2003).
Description:
Abstract
Formation of methylated metabolites is a critical step in the metabolism of inorganic arsenic or selenium. We have previously shown that under conditions of a concurrent exposure selenite inhibits methylation of arsenite by cultured rat hepatocytes. Here, we compare the effects of selenite and mono-, di-, and trimethylated selenium compounds on the methylation of arsenite by purified recombinant rat AsIII-methyltransferase (Cyt19) and by primary rat and human hepatocytes. Among these compounds, selenite was the most potent inhibitor of the methylation of arsenite by the recombinant enzyme (Ki = 1.4 M) and by cultured cells. In both systems, methylseleninic acid was an order of magnitude less potent an inhibitor (Ki = 19.4 M) than was selenite. Dimethylselenoxide and trimethylselenonium iodide were weak activators of recombinant AsIII-methyltransferase activity, but were weak inhibitors of arsenite methylation in hepatocytes. These data suggest that selenite, rather than its methylated metabolites, is responsible for inhibition of arsenite methylation in cultured hepatocytes and that inhibition may involve direct interactions between selenite and AsIII-methyltransferase.
This manuscript as reviewed by NHEERL and approved for publication. Approval does not
necessarily reflect the views or policy of EPA nor does mention of trade names constitute
endorsement by the Agency.